Skip to content

Clinical trials

Phase 1 Carcinoma, Hepatocellular trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 1 Country / region: France Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20092
20101
20111
20121
20152
20163
20173
20192
20202
20213
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting4
Active, not recruiting3
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
Exelixis2
Incyte Corporation2
Bayer1
Blueprint Medicines Corporation1
Celgene1
Center Eugene Marquis1
Centre Hospitalier Universitaire Dijon1
Eisai Co., Ltd.1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular25
Carcinoma, Non-Small-Cell Lung9
Neoplasms7
Stomach Neoplasms7
Triple Negative Breast Neoplasms7
Squamous Cell Carcinoma of Head and Neck6
Colorectal Neoplasms5
Ovarian Neoplasms5
Carcinoma, Merkel Cell4
Carcinoma, Renal Cell4

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.